Skip to content
Search

Latest Stories

Alliance Healthcare pledges to achieve net zero carbon footprint by 2030

Alliance Healthcare, the UK’s largest pharmaceutical wholesaler, has pledged to support the global efforts to cut carbon emissions, as set out at the recent UN Climate Change Conference, COP26.

The company’s pledge is in line with its aim to create “healthier futures and the business”, on which it has been working on for years.


It aims to become the most sustainable independent full-line pharmaceutical wholesaler in the UK by 2030, ensuring to remain the sustainable partner of choice for its customers and manufacturers.

Alliance Healthcare UK driver stacking totes outside van 2 Alliance Healthcare UK driver stacking totes outside van

To achieve the target, Alliance Healthcare has listed some steps, such as reduction in use of single-use plastic in the UK business by 60 per cent by September 2022, switch from plastic bubble wrap to a paper alternative, ensure responsible sourcing of materials, water and energy conservation.

Julian Mount, managing director, Alliance Healthcare UK said, it is “vital that we make this pledge and work hard to meet the commitments and targets we have set to achieve by 2030.

“I firmly believe that by working in partnership with industry partners and supporting their commitments as well as our own ensures we are all on the same path in our mission to tackle climate change.”

He added that it is everyone’s duty to tackle climate change and “strive to meet the global targets.”

Mount said: “Today everyone at Alliance Healthcare is encouraged to make a personal sustainability pledge on our internal pledge trees, as we all continue to play a personal role in this commitment.”

Earlier this year, Alliance Healthcare’s parent company - AmerisourceBergen committed to Science-Based Targets (SBTs) and announced an interim target which the Alliance Healthcare UK business will be supporting.

SBTs provide a clearly-defined pathway for companies to reduce greenhouse gas emissions, helping prevent the worst impacts of climate change and future-proof business growth.

Gina Clark, executive vice president and chief communications & administration officer for AmerisourceBergen, said: “We are committed to fostering a positive impact on people and planet through the work we do and the communities we serve”.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less